Literature DB >> 22385232

Immunology in the clinic review series; focus on type 1 diabetes and viruses: the enterovirus link to type 1 diabetes: critical review of human studies.

L C Stene1, M Rewers.   

Abstract

The hypothesis that under some circumstances enteroviral infections can lead to type 1 diabetes (T1D) was proposed several decades ago, based initially on evidence from animal studies and sero-epidemiology. Subsequently, enterovirus RNA has been detected more frequently in serum of patients than in control subjects, but such studies are susceptible to selection bias and reverse causality. Here, we review critically recent evidence from human studies, focusing on longitudinal studies with potential to demonstrate temporal association. Among seven longitudinal birth cohort studies, the evidence that enterovirus infections predict islet autoimmunity is quite inconsistent in our interpretation, due partially, perhaps, to heterogeneity in study design and a limited number of subjects studied. An association between enterovirus and rapid progression from autoimmunity to T1D was reported by one longitudinal study, but although consistent with evidence from animal models, this novel observation awaits replication. It is possible that a potential association with initiation and/or progression of islet autoimmunity can be ascribed to a subgroup of the many enterovirus serotypes, but this has still not been investigated properly. There is a need for larger studies with frequent sample intervals and collection of specimens of sufficient quality and quantity for detailed characterization of enterovirus. More research into the molecular epidemiology of enteroviruses and enterovirus immunity in human populations is also warranted. Ultimately, this knowledge may be used to devise strategies to reduce the risk of T1D in humans.
© 2011 The Authors. Clinical and Experimental Immunology © 2011 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22385232      PMCID: PMC3390488          DOI: 10.1111/j.1365-2249.2011.04555.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  87 in total

1.  Comparative evaluation of Taqman real-time PCR and semi-nested VP1 PCR for detection of enteroviruses in clinical specimens.

Authors:  M Steven Oberste; Silvia Peñaranda; Shannon L Rogers; Elizabeth Henderson; W Allan Nix
Journal:  J Clin Virol       Date:  2010-07-27       Impact factor: 3.168

Review 2.  High-throughput DNA sequencing--concepts and limitations.

Authors:  Martin Kircher; Janet Kelso
Journal:  Bioessays       Date:  2010-06       Impact factor: 4.345

3.  Rapid group-, serotype-, and vaccine strain-specific identification of poliovirus isolates by real-time reverse transcription-PCR using degenerate primers and probes containing deoxyinosine residues.

Authors:  David R Kilpatrick; Chen-Fu Yang; Karen Ching; Annelet Vincent; Jane Iber; Ray Campagnoli; Mark Mandelbaum; Lina De; Su-Ju Yang; Allan Nix; Olen M Kew
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

Review 4.  Sequencing technologies - the next generation.

Authors:  Michael L Metzker
Journal:  Nat Rev Genet       Date:  2009-12-08       Impact factor: 53.242

5.  Detection of enterovirus RNA in peripheral blood mononuclear cells of type 1 diabetic patients beyond the stage of acute infection.

Authors:  Barbara M Schulte; Judith Bakkers; Kjerstin H W Lanke; Willem J G Melchers; Ciska Westerlaken; Wil Allebes; Henk-Jan Aanstoot; G Jan Bruining; Gosse J Adema; Frank J M Van Kuppeveld; Jochem M D Galama
Journal:  Viral Immunol       Date:  2010-02       Impact factor: 2.257

6.  Expression of toll-like receptors in the pancreas of recent-onset fulminant type 1 diabetes.

Authors:  Saeko Shibasaki; Akihisa Imagawa; Sisko Tauriainen; Morio Iino; Maarit Oikarinen; Hitoshi Abiru; Keiji Tamaki; Hiroaki Seino; Katsuhiro Nishi; Izumi Takase; Yoshikatsu Okada; Sae Uno; Yuko Murase-Mishiba; Jungo Terasaki; Hideichi Makino; Iichiro Shimomura; Heikki Hyöty; Toshiaki Hanafusa
Journal:  Endocr J       Date:  2009-12-12       Impact factor: 2.349

7.  The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes.

Authors:  S J Richardson; A Willcox; A J Bone; A K Foulis; N G Morgan
Journal:  Diabetologia       Date:  2009-03-06       Impact factor: 10.122

8.  Immunoregulatory mechanisms triggered by viral infections protect from type 1 diabetes in mice.

Authors:  Christophe M Filippi; Elizabeth A Estes; Janine E Oldham; Matthias G von Herrath
Journal:  J Clin Invest       Date:  2009-05-26       Impact factor: 14.808

Review 9.  Improvement of a real-time RT-PCR assay for the detection of enterovirus RNA.

Authors:  Marian A C Piqueur; Walter A Verstrepen; Peggy Bruynseels; An H Mertens
Journal:  Virol J       Date:  2009-07-07       Impact factor: 4.099

Review 10.  Enteroviruses, type 1 diabetes and hygiene: a complex relationship.

Authors:  S Tracy; K M Drescher; J D Jackson; K Kim; K Kono
Journal:  Rev Med Virol       Date:  2010-03       Impact factor: 6.989

View more
  34 in total

1.  Viruses and type 1 diabetes: ignorance acquires a better vocabulary.

Authors:  E A M Gale
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

Review 2.  Immunology in the clinic review series; focus on type 1 diabetes and viruses: the innate immune response to enteroviruses and its possible role in regulating type 1 diabetes.

Authors:  K Lind; M H Hühn; M Flodström-Tullberg
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

Review 3.  The prenatal environment and type 1 diabetes.

Authors:  L C Stene; E A M Gale
Journal:  Diabetologia       Date:  2013-05-10       Impact factor: 10.122

4.  Next-generation sequencing for viruses in children with rapid-onset type 1 diabetes.

Authors:  H-S Lee; T Briese; C Winkler; M Rewers; E Bonifacio; H Hyoty; M Pflueger; O Simell; J X She; W Hagopian; Å Lernmark; B Akolkar; J Krischer; A G Ziegler
Journal:  Diabetologia       Date:  2013-05-09       Impact factor: 10.122

5.  Long term effect of gut microbiota transfer on diabetes development.

Authors:  Jian Peng; Sukanya Narasimhan; Julian R Marchesi; Andrew Benson; F Susan Wong; Li Wen
Journal:  J Autoimmun       Date:  2014-04-22       Impact factor: 7.094

6.  Broadening the translational immunology landscape.

Authors:  M Peakman
Journal:  Clin Exp Immunol       Date:  2012-12       Impact factor: 4.330

Review 7.  Immunology in the clinic review series; focus on type 1 diabetes and viruses: role of antibodies enhancing the infection with Coxsackievirus-B in the pathogenesis of type 1 diabetes.

Authors:  D Hober; F Sane; H Jaïdane; K Riedweg; A Goffard; R Desailloud
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

Review 8.  Immunology in the clinic review series; focus on type 1 diabetes and viruses: how viral infections modulate beta cell function.

Authors:  F A Grieco; G Sebastiani; I Spagnuolo; A Patti; F Dotta
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

Review 9.  Immunology in the clinic review series: focus on type 1 diabetes and viruses: the role of viruses in type 1 diabetes: a difficult dilemma.

Authors:  K T Coppieters; A Wiberg; S M Tracy; M G von Herrath
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

10.  From immunobiology to β-cell biology: the changing perspective on type 1 diabetes.

Authors:  Aarthi Maganti; Carmella Evans-Molina; Raghavendra Mirmira
Journal:  Islets       Date:  2014       Impact factor: 2.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.